105 related articles for article (PubMed ID: 7809505)
1. Molecular pathology of human neuroblastomas.
Brodeur GM
Semin Diagn Pathol; 1994 May; 11(2):118-25. PubMed ID: 7809505
[TBL] [Abstract][Full Text] [Related]
2. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
[TBL] [Abstract][Full Text] [Related]
4. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
[TBL] [Abstract][Full Text] [Related]
6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
7. Expression of TrkC in favorable human neuroblastomas.
Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM
Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
9. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells.
Pastor R; Bernal J; Rodríguez-Peña A
Oncogene; 1994 Apr; 9(4):1081-9. PubMed ID: 8134111
[TBL] [Abstract][Full Text] [Related]
10. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
Tanaka T; Sugimoto T; Sawada T
Cancer; 1998 Oct; 83(8):1626-33. PubMed ID: 9781958
[TBL] [Abstract][Full Text] [Related]
11. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.
Nakagawara A; Nakamura Y; Ikeda H; Hiwasa T; Kuida K; Su MS; Zhao H; Cnaan A; Sakiyama S
Cancer Res; 1997 Oct; 57(20):4578-84. PubMed ID: 9377572
[TBL] [Abstract][Full Text] [Related]
12. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
14. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
Miyake M; Suzuki T; Shimada H; Stram D; Seeger RC
Prog Clin Biol Res; 1994; 385():163-8. PubMed ID: 7972208
[No Abstract] [Full Text] [Related]
15. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
16. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
[TBL] [Abstract][Full Text] [Related]
17. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
18. [Neuroblastoma].
Sawada T; Komatsu H; Shirai C; Yamamoto S; Ishiwari K; Ishida H; Ohmizono Y; Matsumura T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):28-36. PubMed ID: 7826075
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
[TBL] [Abstract][Full Text] [Related]
20. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
